Presentation TCT 2016 Early and Late Results With the Occlutech LAA Occluder (and Future studies) Presenter: Horst Sievert October 30, 2016 REGISTER for free or LOG IN to view this content Structural Heart Presentation TCT 2016 Left Atrial Appendage Up Next Presentation TCT 2016 Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? Yes Minimize Bleeding Risk and Improve Long-term Outcomes! Presenter: Brian K. Whisenant October 30, 2016 More slides + Presentation TCT 2016 Whats New and What's Controversial in the US and EU Guidelines? Presenter: Catherine M. Otto October 30, 2016 Presentation TCT 2016 A Bioskills Primer for Mitral Valve Device Inventors and Interventionalists Presenter: Mark Reisman October 30, 2016 We Recommend
Presentation TCT 2016 Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? Yes Minimize Bleeding Risk and Improve Long-term Outcomes! Presenter: Brian K. Whisenant October 30, 2016
Presentation TCT 2016 Whats New and What's Controversial in the US and EU Guidelines? Presenter: Catherine M. Otto October 30, 2016
Presentation TCT 2016 A Bioskills Primer for Mitral Valve Device Inventors and Interventionalists Presenter: Mark Reisman October 30, 2016